AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation

Zsolt Juranyi, Nora Sziray, Bernadett Marko, Gyorgy Levay, L. Hársing

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The release of [3H]dopamine was measured in rat corticostriatal slice preparations that contained the striatum and the adjacent prefrontal cortex to maintained glutamatergic corticostriatal afferentation. These slices were prepared from either nontreated or 6-hydroxydopamine-pretreated rats. The slices were loaded with [3H]dopamine, submerged in a two-compartment bath so that the cortical region was contained in one compartment, the corpus callosum was passed through a silicone greased slot, and the striatal region was contained in the other compartment. The cortical and the striatal parts were supervised with Krebs-bicarbonate buffer independently. The release of [ 3H]dopamine was determined from the striatal part at rest and in response to electrical stimulation of the cortical area. Electrical stimulation of the cortical part increased the release of [3H]dopamine from the striatal part of the slices, and this release was found to be higher after lesion of the nigrostriatal dopaminergic pathway with 6-hydroxydopamine. Cortically evoked [3H]dopamine release was even higher in the presence of the dopamine precursor L-DOPA after 6-hydroxdopamine lesion. Perfusion of GYKI-53405, a noncompetitive AMPA receptor antagonist, in combination with L-DOPA further increased both basal and stimulation-evoked [3H]dopamine release, whereas GYKi-53405 by itself did not influence basal [3H]dopamine outflow from striatum. These findings indicate that, in parkinsonian striatum, the stimulatory effect of L-DOPA on dopamine release is potentiated by AMPA receptor blockade, and the antiparkinsonian effect of GYKI-53405 may be due to its L-DOPA sparing effect.

Original languageEnglish
Pages (from-to)129-139
Number of pages11
JournalCritical Reviews in Neurobiology
Volume16
Issue number1-2
DOIs
Publication statusPublished - 2004

Fingerprint

AMPA Receptors
Dopamine
Corpus Striatum
GYKI 53405
Oxidopamine
Electric Stimulation
Antiparkinson Agents
Corpus Callosum
Silicones
Bicarbonates
Prefrontal Cortex
Baths
Buffers
Perfusion

Keywords

  • 6-hydroxydopamine
  • [H]dopamine release
  • Corticostriatal slice
  • GYKI-53405
  • L-DOPA

ASJC Scopus subject areas

  • Clinical Neurology
  • Physiology
  • Neuroscience(all)

Cite this

AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation. / Juranyi, Zsolt; Sziray, Nora; Marko, Bernadett; Levay, Gyorgy; Hársing, L.

In: Critical Reviews in Neurobiology, Vol. 16, No. 1-2, 2004, p. 129-139.

Research output: Contribution to journalArticle

@article{b9848b15b52140dbbe7b7ce40efc58f6,
title = "AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation",
abstract = "The release of [3H]dopamine was measured in rat corticostriatal slice preparations that contained the striatum and the adjacent prefrontal cortex to maintained glutamatergic corticostriatal afferentation. These slices were prepared from either nontreated or 6-hydroxydopamine-pretreated rats. The slices were loaded with [3H]dopamine, submerged in a two-compartment bath so that the cortical region was contained in one compartment, the corpus callosum was passed through a silicone greased slot, and the striatal region was contained in the other compartment. The cortical and the striatal parts were supervised with Krebs-bicarbonate buffer independently. The release of [ 3H]dopamine was determined from the striatal part at rest and in response to electrical stimulation of the cortical area. Electrical stimulation of the cortical part increased the release of [3H]dopamine from the striatal part of the slices, and this release was found to be higher after lesion of the nigrostriatal dopaminergic pathway with 6-hydroxydopamine. Cortically evoked [3H]dopamine release was even higher in the presence of the dopamine precursor L-DOPA after 6-hydroxdopamine lesion. Perfusion of GYKI-53405, a noncompetitive AMPA receptor antagonist, in combination with L-DOPA further increased both basal and stimulation-evoked [3H]dopamine release, whereas GYKi-53405 by itself did not influence basal [3H]dopamine outflow from striatum. These findings indicate that, in parkinsonian striatum, the stimulatory effect of L-DOPA on dopamine release is potentiated by AMPA receptor blockade, and the antiparkinsonian effect of GYKI-53405 may be due to its L-DOPA sparing effect.",
keywords = "6-hydroxydopamine, [H]dopamine release, Corticostriatal slice, GYKI-53405, L-DOPA",
author = "Zsolt Juranyi and Nora Sziray and Bernadett Marko and Gyorgy Levay and L. H{\'a}rsing",
year = "2004",
doi = "10.1615/CritRevNeurobiol.v16.i12.140",
language = "English",
volume = "16",
pages = "129--139",
journal = "Critical Reviews in Neurobiology",
issn = "0892-0915",
publisher = "Begell House Inc.",
number = "1-2",

}

TY - JOUR

T1 - AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation

AU - Juranyi, Zsolt

AU - Sziray, Nora

AU - Marko, Bernadett

AU - Levay, Gyorgy

AU - Hársing, L.

PY - 2004

Y1 - 2004

N2 - The release of [3H]dopamine was measured in rat corticostriatal slice preparations that contained the striatum and the adjacent prefrontal cortex to maintained glutamatergic corticostriatal afferentation. These slices were prepared from either nontreated or 6-hydroxydopamine-pretreated rats. The slices were loaded with [3H]dopamine, submerged in a two-compartment bath so that the cortical region was contained in one compartment, the corpus callosum was passed through a silicone greased slot, and the striatal region was contained in the other compartment. The cortical and the striatal parts were supervised with Krebs-bicarbonate buffer independently. The release of [ 3H]dopamine was determined from the striatal part at rest and in response to electrical stimulation of the cortical area. Electrical stimulation of the cortical part increased the release of [3H]dopamine from the striatal part of the slices, and this release was found to be higher after lesion of the nigrostriatal dopaminergic pathway with 6-hydroxydopamine. Cortically evoked [3H]dopamine release was even higher in the presence of the dopamine precursor L-DOPA after 6-hydroxdopamine lesion. Perfusion of GYKI-53405, a noncompetitive AMPA receptor antagonist, in combination with L-DOPA further increased both basal and stimulation-evoked [3H]dopamine release, whereas GYKi-53405 by itself did not influence basal [3H]dopamine outflow from striatum. These findings indicate that, in parkinsonian striatum, the stimulatory effect of L-DOPA on dopamine release is potentiated by AMPA receptor blockade, and the antiparkinsonian effect of GYKI-53405 may be due to its L-DOPA sparing effect.

AB - The release of [3H]dopamine was measured in rat corticostriatal slice preparations that contained the striatum and the adjacent prefrontal cortex to maintained glutamatergic corticostriatal afferentation. These slices were prepared from either nontreated or 6-hydroxydopamine-pretreated rats. The slices were loaded with [3H]dopamine, submerged in a two-compartment bath so that the cortical region was contained in one compartment, the corpus callosum was passed through a silicone greased slot, and the striatal region was contained in the other compartment. The cortical and the striatal parts were supervised with Krebs-bicarbonate buffer independently. The release of [ 3H]dopamine was determined from the striatal part at rest and in response to electrical stimulation of the cortical area. Electrical stimulation of the cortical part increased the release of [3H]dopamine from the striatal part of the slices, and this release was found to be higher after lesion of the nigrostriatal dopaminergic pathway with 6-hydroxydopamine. Cortically evoked [3H]dopamine release was even higher in the presence of the dopamine precursor L-DOPA after 6-hydroxdopamine lesion. Perfusion of GYKI-53405, a noncompetitive AMPA receptor antagonist, in combination with L-DOPA further increased both basal and stimulation-evoked [3H]dopamine release, whereas GYKi-53405 by itself did not influence basal [3H]dopamine outflow from striatum. These findings indicate that, in parkinsonian striatum, the stimulatory effect of L-DOPA on dopamine release is potentiated by AMPA receptor blockade, and the antiparkinsonian effect of GYKI-53405 may be due to its L-DOPA sparing effect.

KW - 6-hydroxydopamine

KW - [H]dopamine release

KW - Corticostriatal slice

KW - GYKI-53405

KW - L-DOPA

UR - http://www.scopus.com/inward/record.url?scp=9744252290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9744252290&partnerID=8YFLogxK

U2 - 10.1615/CritRevNeurobiol.v16.i12.140

DO - 10.1615/CritRevNeurobiol.v16.i12.140

M3 - Article

VL - 16

SP - 129

EP - 139

JO - Critical Reviews in Neurobiology

JF - Critical Reviews in Neurobiology

SN - 0892-0915

IS - 1-2

ER -